About Jeffrey Leiden
Jeffrey Leiden is a director at Odyssey Therapeutics.
Jeffrey Leiden reports to the SEC as a director or officer of 6 public companies, including Vertex Pharmaceuticals Inc. / Ma (VRTX), Revolution Healthcare Acquisition (REVH) and Quest Diagnostics (DGX).
Jeffrey Leiden first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Leiden in the role, so the role may have started earlier or lasted longer.
VM
Vertex Pharmaceuticals Inc. / Ma
Executive Chairman
2009 – 2026 · Public company (VRTX)
RC
Revolution Healthcare Acquisition Corp.
Director
2021 · Public company (REVH)
QI
Quest Diagnostics Inc.
Director
2014 – 2018 · Public company (DGX)
MI
Millennium Pharmaceuticals Inc.
Director
2007 – 2008 · Public company (MLNM)
AL
Abbott Laboratories
President and COO, director
2006 · Public company (ABT)
Key Colleagues at Startups
The people Jeffrey Leiden works with at each company, as listed on that company's latest Form D.
Odyssey Therapeutics, Inc. · Form D, Dec 4, 2025
VO
Valerie Odegard
Director
CG
Carl Gordon
Director
CN
Carolyn Ng
Director
GG
Gary Glick
President & CEO, director
TW
Timothy Walbert
Director
Paulina Hill
Director
NL
Nan Li
Director
JH
Jason Haas
CFO
NT
Nia Tatsis
Director
KP
Ksenija Pavletic
Director
SC
Shelley Chu
Director
LS
Lan Smith
Director
JC
Jill Carroll
Director